These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28779229)

  • 41. Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling.
    Wei Y; Cui C; Lainscak M; Zhang X; Li J; Huang J; Zhang H; Zheng Z; Hu S
    J Cell Mol Med; 2011 Apr; 15(4):773-82. PubMed ID: 20219015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo.
    Vassilev V; Pretto CM; Cornet PB; Delvaux D; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5848-57. PubMed ID: 16046583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
    Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural and functional insights into the interaction of sulfated glycosaminoglycans with tissue inhibitor of metalloproteinase-3 - A possible regulatory role on extracellular matrix homeostasis.
    Rother S; Samsonov SA; Hofmann T; Blaszkiewicz J; Köhling S; Moeller S; Schnabelrauch M; Rademann J; Kalkhof S; von Bergen M; Pisabarro MT; Scharnweber D; Hintze V
    Acta Biomater; 2016 Nov; 45():143-154. PubMed ID: 27545813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined evaluation of matrix metalloproteinases and their inhibitors has better clinical utility in oral cancer.
    Singh RD; Nilayangode H; Patel JB; Shah FD; Shukla SN; Shah PM; Patel PS
    Int J Biol Markers; 2011; 26(1):27-36. PubMed ID: 21337314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic Determinants of the Biologic Variation of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Stable Systolic Chronic Heart Failure.
    Täger T; Wiedergruen AK; Fröhlich H; Cebola R; Corletto A; Horsch A; Hess G; Slottje K; Zdunek D; Katus HA; Wians FH; Frankenstein L
    J Card Fail; 2017 Dec; 23(12):835-842. PubMed ID: 28757153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
    Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
    J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression of remodeling markers by tissue structure in nasal polyposis.
    de Borja Callejas F; Picado C; Martínez-Antón A; Alobid I; Pujols L; Valero A; Roca-Ferrer J; Mullol J
    Am J Rhinol Allergy; 2013; 27(3):e69-74. PubMed ID: 23710947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
    Jia Y; Hu DN; Sun J; Zhou J
    Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.
    Alvarez-Sabín J; Delgado P; Abilleira S; Molina CA; Arenillas J; Ribó M; Santamarina E; Quintana M; Monasterio J; Montaner J
    Stroke; 2004 Jun; 35(6):1316-22. PubMed ID: 15087562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix Metalloproteinases and Their Tissue Inhibitors: an Evaluation of Novel Biomarkers in ANCA-Associated Vasculitis.
    Zakiyanov O; Chocová Z; Hrušková Z; Hladinová Z; Kalousová M; Maličková K; Vachek J; Wurmová P; Kříha V; Zima T; Tesař V
    Folia Biol (Praha); 2019; 65(5-6):227-236. PubMed ID: 32362306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease.
    Heider P; Pelisek J; Poppert H; Eckstein HH
    Vasc Endovascular Surg; 2009 Dec; 43(6):551-60. PubMed ID: 19640916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases].
    Zhao Y; Zhou X; Liao X; Yang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):790-5. PubMed ID: 19734590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
    Hansson J; Lind L; Hulthe J; Sundström J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):297-303. PubMed ID: 19387352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MMPs and TIMPs expression in facial tissue of children with cleft lip and palate.
    Smane-Filipova L; Pilmane M; Akota I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):538-542. PubMed ID: 27876897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.